B7-H3 / CD276 Antibody (FITC), Mouse MAb
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Antibody > Mouse MAb Antibody > B7-H3 / CD276 Antibody (FITC), Mouse MAb

B7-H3 / CD276 Antibody (FITC), Mouse MAb PDF Download

Catalog   Size (Price) Quantity In Stock Operation

Primary antibody | Secondary antibody | Tag antibody | Isotype control antibody | Loading control antibody | Antibody Purification

B7-H3 / CD276 Antibody Datasheet

  Order or Inquire for B7-H3 / CD276 Antibody product Quality antibodies Antibody production services

B7-H3 / CD276 Antibody Product Information

Immunogen :

Recombinant Human B7-H3 / CD276 protein (Catalog#11188-H08H)

Reagents : FITC-conjugated mouse monoclonal antibody

Clone ID :


Ig Type :

Mouse IgG2b

Concentration :

10 μl/Test, 0.1 mg/ml

Formulation : Aqueous solution containing 0.5% BSA and 0.09% sodium azide
Preparation :

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human B7-H3 / CD276 (rh B7-H3 / CD276; Catalog#11188-H08H; Q5ZPR3-1; Met 1-Thr 461) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.

B7-H3 / CD276 Antibody Usage Guide

Specificity :

Human B7-H3 / CD276

  No cross-reactivity in WB and ELISA with

Human cell lysate (293 cell line)

Flow Cytometry :
B7-H3 / CD276 Flow Cytometry

Flow cytometric analysis of anti-B7H3 (CD276) reactivity on PC-3 cells.

Flow cytometry was performed on a BD FACSCalibur flow cytometry system

Please refer to www.sinobiological.com/Flow-Cytometry-FACS-Protocols-a-750.html for technical protocols.

Storage : This antibody is stable for 12 months from date of receipt when stored at 2℃- 8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

B7-H3 / CD276 Antibody Related Products & Topics

B7-H3 / CD276 Antibody Background

B7-H3 is one of the most recently identified members of the B7/CD28 superfamily of costimulatory molecules serving as an accessory modulator of T-cell response. B7 family molecules, which are expressed on antigen-presenting cells and display extracellular regions containing immunoglobulin (Ig) variable (V)- and constant (C)-like domains, are known to modulate T cell receptor (TCR)-mediated T cell activation by providing co-signals that are either stimulatory or inhibitory. B7-H3 provides a stimulatory signal to T cells. However, recent studies suggest a negative regulatory role for B7-H3 in T cell responses. B7-H3 inhibited T cell proliferation mediated by antibody to T cell receptor or allogeneic antigen-presenting cells. B7-H3 is a negative regulator that preferentially affects T (H)1 responses. B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. Recently, B7-H3 expression has also been found in a variety of different human cancers, including prostate cancer, clear cell renal cell carcinoma (ccRCC), non-small-cell lung cancer (NSCLC), pancreatic cancer, gastric cancer, ovarian cancer, colorectal cancer (CRC) and urothelial cell carcinoma. B7-H3 was expressed in some human cancers and correlated with poor outcome of cancer patients.


  1. Loos M. et al., 2010, Clin Dev Immunol. 2010: 683875.
  2. Nagashima O. et al., 2008, J Immunol. 181 (6): 4062-71.
  3. Suh WK. et al., 2003, Nat Immunol. 4 (9): 899-906.
  4. Waschbisch A. et al., 2008, Arthritis Rheum. 58 (11): 3600-8.
  5. Sun J. et al., 2010, Cancer Immunol Immunother. 59 (8): 1163-71.